Asia-Pacific Bone Marrow Biopsy Market, By Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Asia-Pacific Bone Marrow Biopsy Market Analysis and Size
The rising prevalence of blood disorders such as leukaemia and aplastic anaemia in both developed and developing countries necessitates bone marrow biopsy treatment. According to a National Cancer Institute report, an estimated 405,815 people in the United States were diagnosed with leukaemia. However, insufficient bone marrow biopsy infrastructure is expected to stymie developing-country markets in the coming years. Invasive procedures such as bone marrow aspiration and biopsy necessitate highly technical skills to collect samples suitable for diagnostic processing and analysis. Needle size and calibre are important considerations in the technique chosen based on the patient's age, gender, and weight.
Data Bridge Market Research analyses that the bone marrow biopsy market value is USD 36.794 million in 2022, is expected to reach USD 60.878 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Bone Marrow Biopsy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
BD (U.S.), Medtronic (Ireland), ARGON MEDICAL (U.S.), Merit Medical Systems (U.S.), Cardinal Health (U.S.), Teleflex Incorporated (U.S.), Biomedical Srl (Italy), BPB MEDICA (Italy), Egemen International (Turkey), hiprove (China), MDL SRL (Italy), SOMATEX Medical Technologies GmbH (Germany), STERYLAB S.r.l. (Italy), Tsunami Medical (Italy), weLLgo Medical Products GmbH (Germany), Zamar Care (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A bone marrow biopsy can detect abnormalities such as bone marrow cancer and blood disorders such as leukaemia and lymphoma, affecting blood cells and bone marrow. During a bone marrow biopsy, a large needle is used to extract a bone marrow sample as well as a small amount of bone. A bone marrow biopsy is an invasive procedure that trained professionals should only perform. As a result, the market benefits greatly from this procedure, which is expected to grow exponentially in the future. Invasive procedures such as bone marrow aspiration and biopsy require a high level of technical skill to collect samples suitable for processing and analysis of the diagnosis.
Asia-Pacific Bone Marrow Biopsy Market Dynamics
Drivers
- Increasing Prevalence of Blood Disorders
Rising demand for bone marrow biopsy as the incidence of blood disorders rises is one of the key drivers driving the growth of the bone marrow biopsy market. Initiatives in research and clinical trials have aided in the growth of the bone marrow biopsy market. Early detection of these disorders is becoming more common, which is driving the use of bone marrow biopsy for treatment. These are the factors driving market growth.
- Advances in Technology in Healthcare Sector
During the forecast period, technological advances in biopsy techniques will drive bone marrow biopsy market growth. For instance, single-use or disposable needles ensure sterility for all procedures while also assisting in the prevention of cross contamination. During the forecast period, this is expected to boost the market. Furthermore, among all biopsy techniques, shave and saucerization biopsies are among the quickest and easiest to perform, and they will have a positive impact on business growth during the forecast period.
Opportunities
- Increase in Diagnosis Rate of Early Detection
Bone marrow biopsy, which aids in the early detection of diseased conditions, outperforms all other techniques. This early detection rate is propelling the market forward and is expected to accelerate during the forecast period.
Restraints/Challenges
- High cost of biopsy tests
The market is rapidly expanding and is expected to expand even more during the forecast period. The most significant impediment may be the high cost of the procedures. Due to the high cost of bone marrow biopsies, people may be hesitant to use this method of diagnosis, which may limit the growth of the bone marrow industry in the future.
This bone marrow biopsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone marrow biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Bone Marrow Biopsy Market
The COVID-19 outbreak has caused an unprecedented global public health crisis that has impacted virtually every business. Its long-term consequences are expected to impact industry growth during the forecast period. Our ongoing research is improving our research strategy to ensure that fundamental COVID-19 concerns and potential solutions are addressed. COVID-19 has improved the lives of patients. Because the coronavirus may damage blood marrow cells in patients with severe COVID-19, the market flourished during and after the pandemic. The majority of patients with mild COVID-19 had their abnormal levels return to normal during their hospital stay. Monocytes did not function properly in COVID-19 patients with severe disease. As a result, bone marrow biopsies are important in this regard.
Asia-Pacific Bone Marrow Biopsy Market Scope
The bone marrow biopsy market is segmented on the basis of product type, procedure type, biopsy type, site, technique, age, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Needles
- Instruments
- Biopsy Gun
- Procedure Trays
- Others
Procedure Type
- Hip Biopsy
- Breastbone (Sternum) Biopsy
- Percutaneous Trephine Biopsy
- Tibia (Shin) Biopsy
- Others
Biopsy Type
- Core Needle Biopsy
- Vacuum-Assisted Biopsy (VAB)
- Fine Needle Aspiration Biopsy
Site
- Posterior Iliac Crest
- Anterior Iliac Crest
- Calcaneus
- Distal Tibia
- Proximal Tibia
- Proximal Humerus
- Others
Technique
- Flow Cytometry
- Fluorescence In Situ Hybridization (Fish)
- Polymerase Chain Reaction (PCR)
- Karyotype Test
- Other
Age
- Geriatric
- Adult
- Pediatric
Application
- Lymphoma Disease
- Leukemia, Polycythemia Vera
- Multiple Myeloma
- Thrombocythemia
- Myelofibrosis
- Aplastic Anemia
- Others
End User
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Academic and Research Organizations
- Others
Bone Marrow Biopsy Market Regional Analysis/Insights
The bone marrow biopsy market is analyzed and market size insights and trends are provided by country, product type, procedure type, biopsy type, site, technique, age, application, end user and distribution channel as referenced above.
The countries covered in the bone marrow biopsy market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China accounted largest market share due to the growing geriatric populace pace in China. Japan grows with nominal CAGR due to its advanced healthcare system. However, due to increased initiative activities by major healthcare organizations and government bodies, India is gaining a reasonable market share.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The bone marrow biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bone marrow biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bone marrow biopsy market. The data is available for historic period 2011-2021.
Competitive Landscape and Bone Marrow Biopsy Market Share Analysis
The bone marrow biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone marrow biopsy market.
Some of the major players operating in the bone marrow biopsy market are:
- BD (U.S.)
- Medtronic (Ireland)
- ARGON MEDICAL (U.S.)
- Merit Medical Systems (U.S.)
- Cardinal Health (U.S.)
- Teleflex Incorporated (U.S.)
- Biomedical Srl (Italy)
- BPB MEDICA (Italy)
- Egemen International (Turkey)
- hiprove (China)
- MDL SRL (Italy)
- SOMATEX Medical Technologies GmbH (Germany)
- STERYLAB S.r.l. (Italy)
- Tsunami Medical (Italy)
- weLLgo Medical Products GmbH (Germany)
- Zamar Care (U.S.)
SKU-